First-ever malaria treatment for infants approved by WHO

Wait 5 sec.

2 min readMay 2, 2026 05:05 PM ISTWHO said the newly prequalified formulation provides an age-appropriate option (AP Photo)For decades, doctors treating malaria in newborns have relied on scaled-down doses of medicines meant for older children, with no formulation designed for even younger patients. That gap has now closed, with the World Health Organization (WHO) prequalifying the first malaria treatment developed specifically for infants weighing between 2 and 5 kg.The treatment, a formulation of artemether-lumefantrine (common brand name: Coartem), allows governments and public health agencies to procure a quality-assured drug tailored to babies and young infants. The WHO, in its statement, said the move will expand access to safer, more accurate treatment for a group that has remained underserved in malaria care.Treatment gap for infantsInfants with malaria have so far received adjusted doses of medicines designed for older children, increasing the risk of errors and side effects. The WHO said the newly prequalified formulation provides an age-appropriate option and addresses safety concerns.WHO Director-General Tedros Adhanom Ghebreyesus said a combination of vaccines, diagnostics and improved treatments is strengthening the global malaria response.New diagnostic testsThe WHO has also prequalified three rapid diagnostic tests to tackle emerging detection challenges. Most existing tests identify the HRP2 protein in Plasmodium falciparum, but some parasite strains no longer produce this protein, leading to missed cases.The new tests detect an alternative protein, pf-LDH, which the WHO said improves accuracy where HRP2-based tests fail. The agency recommends countries switch when more than 5% of infections go undetected due to such mutations.Global burdenMalaria caused an estimated 282 million cases and 610,000 deaths in 2024, according to World Malaria Report 2025. Children under five account for a majority of deaths, largely in Africa.Story continues below this adWHO said global progress has slowed due to drug and insecticide resistance, diagnostic gaps and declining international funding, despite major gains since 2000, including billions of infections prevented.The Express Global Desk at The Indian Express delivers authoritative, verified, and context-driven coverage of key international developments shaping global politics, policy, and migration trends. The desk focuses on stories with direct relevance for Indian and global audiences, combining breaking news with in-depth explainers and analysis. A major focus area of the desk is US immigration and visa policy, including developments related to student visas, work permits, permanent residency pathways, executive actions, and court rulings. The Global Desk also closely tracks Canada’s immigration, visa, and study policies, covering changes to study permits, post-study work options, permanent residence programmes, and regulatory updates affecting migrants and international students. All reporting from the Global Desk adheres to The Indian Express’ editorial standards, relying on official data, government notifications, court documents, and on-record sources. The desk prioritises clarity, accuracy, and accountability, ensuring readers can navigate complex global systems with confidence. Core Team The Express Global Desk is led by a team of experienced journalists and editors with deep expertise in international affairs and migration policy: Aniruddha Dhar – Senior Assistant Editor with extensive experience in global affairs, international politics, and editorial leadership. Nischai Vats – Deputy Copy Editor specialising in US politics, US visa and immigration policy, and policy-driven international coverage. Mashkoora Khan – Sub-editor focusing on global developments, with a strong emphasis on Canada visa, immigration, and study-related policy coverage. ... Read MoreStay updated with the latest - Click here to follow us on Instagram© The Indian Express Pvt LtdAdvertisementLoading Recommendations...May 02: Latest News01Thomas Cup: Lakshya Sen, Satwik-Chirag overcome doubts and disappointments, take matters into their own hands to put India on road to victory02Thomas Cup: How Ayush Shetty came of age on the big stage, taking India to the semifinals with a display of maturity and composure03Imprisoned Iranian Nobel laureate Narges Mohammadi transferred to hospital04Russian Athletics Federation announces India tie-up, AFI says no MoU signed05Slow-healing wounds, hair loss, and cold toes: When to see a doctor for potential heart issuesAdvertisementLive BlogPatriot Box Office Collection Day 1 Live Updates: Mohanlal–Mammootty film nears Rs 9 cr in Kerala, mints Rs 29 cr worldwide2 minutes agoIPL 2026 CSK vs MI LIVE Score, Playing 11 Updates: Focus on Dhoni, Rohit’s fitness as Chennai take on Mumbai at Chepauk3 minutes agoBseodisha.ac.in, BSE Odisha Class 10th Result 2026 LIVE Updates: 95.33% students pass, link at bseodisha.nic.in shortly4 minutes agoIran-US War Ceasefire Live Updates: US to withdraw 5,000 troops from Germany, fulfilling Trump’s threat5 minutes agoRaja Shivaji Box Office Collection Day 1 Live Updates: Riteish Deshmukh-starrer nears Rs 15 cr, becomes biggest Marathi opener11 minutes ago